Another step towards understanding the causes of narcolepsy

December 09, 2004

This release is also available in German.

Results of a preliminary study in this week's issue of THE LANCET suggest a step forward in our understanding of the processes behind narcolepsy; there appears to be an underlying autoimmune process for people with a certain genetic profile. Future diagnostic testing of people with this profile should lead to substantial improvements in disease treatment.

Narcolepsy is a chronic disabling sleep-wake disorder characterised by excessive daytime sleepiness, which is caused by changes in hormone concentrations and nervous system activity. Tom Gordon (Flinders University, South Australia) and colleagues induced narcolepsy-like symptoms in smooth muscles of mice by injecting antibodies from blood samples of 9 people with confirmed narcolepsy. Mice injected with antibodies from 9 people who did not have narcolepsy (the control group) did not develop such symptoms.

Professor Gordon comments: "Our findings suggest that the functional autoantibody is a sensitive and specific marker for human narcolepsy and might lead to a clinically useful assay for diagnosing narcolepsy... Identification of the target of the autoantibody and a better understanding of its long-term effects could open up new possibilities for diagnosis and management of this disabling disease."

In an accompanying commentary (p 2076), Merrill S Wise (Baylor College of Medicine, Houston, USA, concludes: "If these preliminary findings are replicated with larger numbers of narcolepsy patients and appropriately selected healthy and diseased controls...[this study] will have opened an exciting new chapter in the narcolepsy story. The investigators might have identified the missing link that connects an autoimmune process to selective loss of hypocretin neurons and the development of narcolepsy. A clinically useful assay could lead to earlier diagnosis and improve the likelihood for effective use of immunomodulators, hypocretin agonists, or perhaps a preventive strategy before loss of hypocretin neurons below a critical threshold.
-end-
Contact: Professor Tom P Gordon, Flinders Medical Centre, Centre for transfusion Medicine, Immunology, Flinders University, Bedford Park, South Australia 5O42, Australia;
T) 61-8-8204-4097;
imtg@flinders.edu.au

Dr Merrill S Wise, Departments of Pediatrics and Neurology, Baylor College of Medicine, Houston, TX 77030, USA; mswise@bcm.tmc.edu

Lancet

Related Narcolepsy Articles from Brightsurf:

Narcolepsy drug did not increase risk of fetal malformation
Modafinil is used to treat conditions such as narcolepsy. Reports have associated the drug with an increased risk of malformation in babies born to mothers who had taken it while pregnant.

Meditation-relaxation therapy may offer escape from the terror of sleep paralysis
Sleep paralysis - a condition thought to explain a number of mysterious experiences including alleged cases of alien abduction and demonic night-time visits - could be treated using a technique of meditation-relaxation, suggests a pilot study published today.

The brain may actively forget during dream sleep
In a study of mice, a team of Japanese and US researchers show that REM sleep may be a time when the brain actively forgets.

New proof that narcolepsy is an autoimmune disease
Researchers from the University of Copenhagen have discovered autoreactive cells in persons suffering from narcolepsy.

Injury to a parent can lead to sleep issues in children and teens
When children face an unsettling experience, such as the injury of a parent, it can alter their sleep habits, according to new research being presented at the 2018 American Academy of Pediatrics National Conference & Exhibition.

The BMJ questions transparency of information surrounding safety of Pandemrix vaccine
An investigation published by The BMJ today raises fundamental questions about the transparency of information surrounding the safety of GlaxoSmithKline's Pandemrix vaccine used in 2009-2010.

Change in brain cells linked to opiate addiction, narcolepsy
Two discoveries -- one in the brains of people with heroin addiction and the other in the brains of sleepy mice -- shed light on chemical messengers in the brain that regulate sleep and addiction.

A wakefulness molecule is abundant in the brains of heroin addicts
Researchers have discovered that the brains of heroin addicts harbor a greater number of neurons that produce hypocretin, a molecule involved in arousal and wakefulness, and one lacking in abundance in people with narcolepsy.

Study points to potential misuse/abuse of ADHD drugs
A new British Journal of Clinical Pharmacology study indicates that methylphenidate, a central nervous system stimulant approved to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, may be subject to misuse and/or abuse.

Sleepless in Latin America: Blind cavefish, extreme environments and insomnia
A study led by researchers from Florida Atlantic University has found that differences in the production of the neuropeptide Hypocretin, previously implicated in human narcolepsy, may explain variation in sleep between animal species, or even between individual people.

Read More: Narcolepsy News and Narcolepsy Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.